Rennova Health Inc

Rennova Health, Inc. engages in the provision of health care services for healthcare providers, patients, and individuals. It operates through the following segments: Clinical Laboratory Operations, and Hospital Operations. The Clinical Laboratory Operations segment specializes in providing urine and blood toxicology and pain medication testing to physicians, clinics, and rehabilitation facilities in the United States. The Hospital Operations segment reflects the operations of Jamestown Regional Medical Center, and Big South Fork Medical Center. The company was founded in December 1989 and is headquartered in West Palm Beach, FL.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Rennova Health, Inc. engages in the provision of healthcare services for healthcare providers, patients, and individuals. It also owns a hospital in Oneida, Tennessee. The company was founded in December 1989 and is headquartered in West Palm Beach, FL.

WEST PALM BEACH, Fla., March 26, 2024 (GLOBE NEWSWIRE) -- Rennova Health, Inc. (OTC: RNVA) announces that certain Series A, B and C warrants to purchase approximately 403,788,906,644 shares of common stock expired on March 21, 2024, and that on March 20, 2024, the Company and certain institutional warrant holders agreed that, with regard to Series B Warrants to acquire 101,350,000,000 shares of common stock, subject to certain terms, the termination date of such Warrants would be extended from March 21, 2024 to December 31, 2025.

RENNOVA HEALTH, INC., ANNOUNCES THE EXPIRATION OF WARRANTS TO PURCHARE OVER FOUR HUNDRED BILLION COMMON SHARES

WEST PALM BEACH, Fla., Jan. 16, 2024 (GLOBE NEWSWIRE) -- Rennova Health, Inc. (OTC: RNVA) Chief Executive Officer, Seamus Lagan provides the following message to shareholders.

RENNOVA HEALTH, INC. CEO PROVIDES JANUARY 2024 MESSAGE TO SHAREHOLDERS

WEST PALM BEACH, Fla., Oct. 25, 2023 (GLOBE NEWSWIRE) -- Rennova Health, Inc. (OTC: RNVA) is pleased to announce a significant debt restructuring with its primary institutional investors. The restructuring extends the maturity date of approximately $8.2 million of secured debt to December 31, 2025, waives historical events of default and removes and/or modifies certain events of default and definitions. In addition, the Company does not expect to recognize default interest in future periods subject to remaining in compliance with covenants and other obligations.

RENNOVA HEALTH, INC. ANNOUNCES SIGNIFICANT DEBT RESTRUCTURING

WEST PALM BEACH, Fla., Aug. 21, 2023 (GLOBE NEWSWIRE) -- Rennova Health, Inc. (OTC: RNVA) Chief Executive Officer Seamus Lagan recently joined Stock Day host Kevin Davis to provide an update after filing the 2023 second quarter financial statements and other information in its Form 10-Q with the SEC.

RENNOVA HEALTH, INC. PROVIDES UPDATE AFTER FILING 2023 SECOND QUARTER FINANCIAL STATEMENTS

WEST PALM BEACH, Fla., Aug. 14, 2023 (GLOBE NEWSWIRE) -- Rennova Health, Inc. (OTC: RNVA) is pleased to announce that its behavioral health services subsidiary, Myrtle Recovery Centers, Inc., (“Myrtle”), has been granted a license under the rules of the Department of Mental Health and Substance Abuse Services of the State of Tennessee to operate an alcohol and drug treatment facility in Oneida, Tennessee. The facility, located at Rennova's Big South Fork Medical Center campus, will commence operations and begin accepting patients today.

RENNOVA HEALTH, INC. ANNOUNCES THE OPENING OF ITS FIRST ALCOHOL AND DRUG TREATMENT FACILITY

WEST PALM BEACH, Fla., June 13, 2023 (GLOBE NEWSWIRE) -- Rennova Health, Inc. (OTC: RNVA) is pleased to announce its critical access hospital in Oneida, Tennessee (Scott County Community Hospital, Inc., d/b/a Big South Fork Medical Center) has received notice from Medicare that it can now be reimbursed using a “swing bed” payment model.

RENNOVA HEALTH, INC. ANNOUNCES THE EXPANSION OF SERVICES AT ITS BIG SOUTH FORK MEDICAL CENTER HOSPITAL, TO INCLUDE SWING BEDS.

WEST PALM BEACH, Fla., April 24, 2023 (GLOBE NEWSWIRE) -- Rennova Health, Inc. (OTC: RNVA) Chief Executive Officer Seamus Lagan recently joined Stock Day host Kevin Davis to provide an update after filing the 2022 financial statements and other information in its Form 10-K with the SEC.

RENNOVA HEALTH, INC. PROVIDES UPDATE AFTER FILING 2022 FINANCIAL STATEMENTS

WEST PALM BEACH, Fla., Feb. 22, 2023 (GLOBE NEWSWIRE) -- Rennova Health, Inc. (OTC: RNVA) Chief Executive Officer Seamus Lagan recently joined Stock Day host Everett Jolly to provide an update on 2022 financial statements and other activities.

RENNOVA HEALTH, INC. PROVIDES UPDATE ON 2022 FINANCIALS AND MYRTLE RECOVERY CENTERS

WEST PALM BEACH, Fla., Oct. 20, 2022 (GLOBE NEWSWIRE) -- Rennova Health, Inc. (OTC: RNVA) Chief Executive Officer Seamus Lagan recently joined Stock Day host Everett Jolly to provide an update on Q3 2022 performance, and other activities.

RENNOVA HEALTH, INC. PROVIDES Q3 2022 PERFORMANCE UPDATE

WEST PALM BEACH, Fla., Sept. 14, 2022 (GLOBE NEWSWIRE) -- Rennova Health, Inc. (OTC: RNVA) Chief Executive Officer Seamus Lagan joined Stock Day host Everett Jolly to provide an update on the business and future plans.

RENNOVA HEALTH, INC. PROVIDES BUSINESS UPDATE

WEST PALM BEACH, Fla., June 16, 2022 (GLOBE NEWSWIRE) -- Rennova Health, Inc. (OTC: RNVA) Chief Executive Officer Seamus Lagan joined Stock Day host Sever Copley to discuss progress with the business and the Company's plans to develop a mental and behavioral health division.

RENNOVA HEALTH, INC. DISCUSSES PROGRESS AND PLANS FOR MENTAL AND BEHAVIORAL HEALTH DIVISION WITH THE STOCK DAY PODCAST

WEST PALM BEACH, Fla., March 16, 2022 (GLOBE NEWSWIRE) -- Rennova Healt h, Inc. (OTC: RNVAD) , today announced that effective at 5:00 pm, Eastern Time, on March 15, 2022 (the “Effective Time”), the Company completed a 1 for 10,000 reverse stock split of its outstanding common stock. The Company's common stock will open for trading on Wednesday March 16, 2022, on a post-split basis and trade under the symbol RNVAD for 20 days.

RENNOVA HEALTH, INC. COMPLETES REVERSE STOCK SPLIT

WEST PALM BEACH, Fla., March 10, 2022 (GLOBE NEWSWIRE) -- Rennova Healt h, Inc. (OTC: RNVA) , today announced that effective at 5:00 pm, Eastern Time, on March 15, 2022 (the “Effective Time”), the Company will effect a 1 for 10,000 reverse stock split of its outstanding common stock. The Company's common stock will open for trading on Wednesday March 16, 2022, on a post-split basis.

RENNOVA HEALTH, INC. ANNOUNCES REVERSE STOCK SPLIT

WEST PALM BEACH, Fla., Dec. 03, 2021 (GLOBE NEWSWIRE) -- R ennova Health, Inc. (OTC: RNVA) today announced that the application by its hospital, Scott County Community Hospital, Inc. (DBA Big South Fork) in Oneida, TN, for designation as a Critical Access Hospital (CAH) has been approved by Centers for Medicare and Medicaid Services (CMS). The effective date of approval is retrospective to June 30, 2021.

RENNOVA HEALTH, INC. OWNED HOSPITAL RECEIVES CRITICAL ACCESS HOSPITAL CERTIFICATION

WEST PALM BEACH, Fla., July 13, 2021 (GLOBE NEWSWIRE) -- Rennova Health, Inc. (OTC: RNVA) (OTC: RNVAW ) , joined Stock Day host Everett Jolly to provide an update on the business and the timing to file the second quarter financial statements.

Rennova Health, Inc., Discusses the Completion of the Separation of Its Software Division and Upcoming 10-Q With the Stock Day Podcast

WEST PALM BEACH, Fla., June 28, 2021 (GLOBE NEWSWIRE) -- Rennova Health, Inc. (OTC: RNVA), (OTC: RNVAW ) (“Rennova” or the “Company”), an owner and operator of rural hospitals in Tennessee, is please to confirm it has closed the agreement with VisualMED Clinical Solutions Corp . (VisualMED) a Nevada based public company, to merge its software and genetic testing interpretation divisions, Health Technology Solutions, Inc. (HTS) and Advanced Molecular Services Group, Inc., (AMSG) and their subsidiaries into VisualMED. These entities will operate as wholly owned subsidiaries of VisualMED which will immediately take the steps required to complete a name and trading symbol change.

RENNOVA IS PLEASED TO REPORT IT HAS CLOSED THE AGREEMENT TO SEPARATE ITS SOFTWARE AND GENETIC DIAGNOSTICS INTERPRETATION DIVISIONS INTO VISUALMED CLINICAL SOLUTIONS CORP. (OTC: VMCS)

WEST PALM BEACH, Fla., June 03, 2021 (GLOBE NEWSWIRE) -- Rennova Health, Inc. (OTC: RNVA), (OTC: RNVAW ) (“Rennova” or the “Company”), an owner and operator of rural hospitals in Tennessee, previously announced that it has completed an agreement with VisualMED Clinical Solutions Corp. (OTC: VMCS) (VisualMED) a Nevada based public company, to merge its software and genetic testing interpretation divisions, Health Technology Solutions, Inc. (HTS) and Advanced Molecular Services Group, Inc., (AMSG) and their subsidiaries into VisualMED. After closing these entities will operate as wholly owned subsidiaries of VisualMED. Closing was subject to a number of customary conditions for a transaction of this nature and was intended to happen on or before May 31 2020.

RENNOVA CONTINUES TO WORK TO CLOSE THE AGREEMENT TO SEPARATE ITS SOFTWARE AND GENETIC DIAGNOSTICS INTERPRETATION DIVISIONS INTO VISUALMED CLINICAL SOLUTIONS CORP. (OTC: VMCS)

WEST PALM BEACH, Fla., May 17, 2021 (GLOBE NEWSWIRE) -- Rennova Health, Inc. (OTC: RNVA), (OTC: RNVAW ) (“Rennova” or the “Company”), an owner and operator of rural hospitals in Tennessee, announces that on May 13, it completed an agreement with VisualMED Clinical Solutions Corp. (VisualMED) a Nevada based public company, to merge its software and genetic testing interpretation divisions, Health Technology Solutions, Inc. (HTS) and Advanced Molecular Services Group, Inc., (AMSG) and their subsidiaries into VisualMED. After closing these entities will operate as wholly owned subsidiaries of VisualMED. Closing is subject to a number of customary conditions for a transaction of this nature and is intended to happen on or before May 31 2020.

RENNOVA COMPLETES AGREEMENT TO SEPARATE ITS SOFTWARE AND GENETIC DIAGNOSTICS INTERPRETATION DIVISIONS INTO VISUALMED CLINICAL SOLUTIONS CORP.

WEST PALM BEACH, Fla., March 08, 2021 (GLOBE NEWSWIRE) -- Rennova Health, Inc. (OTC: RNVA), (OTC: RNVAW) (“Rennova” or the “Company”), an owner and operator of rural hospitals in Tennessee, announces that on March 5, 2021, it terminated discussions with TPT Global Tech, Inc. to merge its software and genetic testing interpretation divisions, Health Technology Solutions, Inc. (HTS) and Advanced Molecular Services Group, Inc., (AMSG) and their subsidiaries into InnovaQor.

RENNOVA TERMINATES DISCUSSIONS WITH TPT GLOBAL TECH, INC.

WEST PALM BEACH, Fla., Jan. 06, 2021 (GLOBE NEWSWIRE) -- Rennova Health, Inc. (OTC: RNVA), (OTC: RNVAW) (“Rennova” or the “Company”), an owner and operator of rural hospitals in Tennessee, announces that on December 31. 2020, it completed an agreement with InnovaQor, Inc. (OTC: INOQ) (InnovaQor) a CO based public company, to merge its software and genetic testing interpretation divisions, Health Technology Solutions, Inc. (HTS) and Advanced Molecular Services Group, Inc., (AMSG) and their subsidiaries into InnovaQor. After closing these entities will operate as wholly owned subsidiaries of InnovaQor. Closing is subject to a number of customary conditions for a transaction of this nature and is intended to happen on or before January 31. 2021.

RENNOVA COMPLETES AGREEMENT TO SEPARATE ITS SOFTWARE AND GENETIC DIAGNOSTICS INTERPRETATION DIVISIONS INTO INNOVAQOR, INC. (OTC: INOQ) [UPDATED]

WEST PALM BEACH, Fla., Jan. 06, 2021 (GLOBE NEWSWIRE) -- Rennova Health, Inc. (OTC: RNVA), (OTC: RNVAW) (“Rennova” or the “Company”), an owner and operator of rural hospitals in Tennessee, announces that on December 31. 2020, it completed an agreement with InnovaQor, Inc. (OTC: INOQ) (InnovaQor) a CO based public company, to merge its software and genetic testing interpretation divisions, Health Technology Solutions, Inc. (HTS) and Advanced Molecular Services Group, Inc., (AMSG) and their subsidiaries into InnovaQor. After closing these entities will operate as wholly owned subsidiaries of InnovaQor. Closing is subject to a number of customary conditions for a transaction of this nature and is intended to happen on or before January 31. 2020.

RENNOVA COMPLETES AGREEMENT TO SEPARATE ITS OFTWARE AND GENETIC DIAGNOSTICS INTERPRETATION DIVISIONS INTO INNOVAQOR, INC. (OTC: INOQ)

WEST PALM BEACH, Fla., Dec. 09, 2020 (GLOBE NEWSWIRE) -- Rennova Health, Inc. (OTC: RNVA), (OTC: RNVAW) (“Rennova” or the “Company”), an owner and operator of rural hospitals in Tennessee, announces that Rennova CEO and President of the Company, Seamus Lagan, joined Stock Day host Everett Jolly for a business update. 

News for Rennova Health Inc Stock (RNVA)